WhatsApp
Click Here
Click Here
|
|||||||||||
 |
TIJER - INTERNATIONAL RESEARCH JOURNAL International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2349-9249 | Impact factor: 8.57 | ESTD Year: 2014
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.57 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
||||||||||
Issue: September 2023
Volume 10 | Issue 9
Last Date : 30-Sep-2023
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.57
Issue per Year : 12
Volume Published : 10
Issue Published : 112
Article Submitted : 9453
Article Published : 2428
Total Authors : 6532
Total Reviewer : 819
Total Countries : 121
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | a brief review on pharmacovigilance: future challenges and opportunities. |
| Authors Name: | Ms. AARTI N. DAMBHE , Ms. Nikita V. Mahalle , Ms. Vaishnavi Khandwe |
| Download E-Certificate: | Download |
| Author Reg. ID: |
TIJER_101428
|
| Published Paper Id: | TIJER2303143 |
| Published In: | Volume 10 Issue 3, March-2023 |
| DOI: | |
| Abstract: | The anticipation and management of illness have changed as a result of prescription drugs and vaccinations. Along with their benefits, therapeutic products can have negative effects as well, some of which may be unexpected or undetectable. Pharmacovigilance is the science and practice involved in the identification, assessment, comprehension, and mitigation of any adverse effects associated with any medication or antibody. Before they are authorized for use, all medications and antibodies must pass rigorous clinical preliminary testing for safety and efficacy. Nevertheless, the clinical pre-cycle contains. Medication and vaccination have revolutionized the prevention and treatment of disease. In addition to their benefits, medicines can have unwanted or unexpected side effects. All medications and vaccines undergo extensive testing for safety and efficacy during clinical trials before being approved for use. However, the process of a clinical trial entails observing these products for a brief period of time in a relatively small number of carefully selected people Recent years have seen a rise in the marketing of innovative therapeutics, digital therapeutics, and specialized adverse drug reaction monitoring systems, frequently following accelerated pathway approval. A few of the opportunities and challenges in this field are briefly discussed. |
| Keywords: | Index Term: pharmacovigilance, adverse drug reaction, opportunities, challenges. |
| Cite Article: | "a brief review on pharmacovigilance: future challenges and opportunities. ", TIJER - International Research Journal (www.tijer.org), ISSN:2349-9249, Vol.10, Issue 3, page no.112-118, March-2023, Available :http://www.tijer.org/papers/TIJER2303143.pdf |
| Downloads: | 00095 |
| ISSN: |
2349-9249 | IMPACT FACTOR: 8.57 Calculated By Google Scholar| ESTD YEAR: 2014 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: TIJER2303143
Registration ID:101428
Published In: Volume 10 Issue 3, March-2023
DOI (Digital Object Identifier):
Page No: 112-118 Country: Yavatmal, Maharashtra , India Research Area: Pharmacy All Publisher : IJ Publication Published Paper URL : https://www.tijer.org/viewpaperforall?paper=TIJER2303143 Published Paper PDF: https://www.tijer.org/papers/TIJER2303143 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.tijer.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2349-9249
Impact Factor: 8.57 and ISSN APPROVED
Journal Starting Year (ESTD) : 2014
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
Indexing Partner |
|||
| Copyright © 2023 - All Rights Reserved - TIJER | |||
Facebook Twitter Instagram LinkedIn